For example, elevated proportions of plasma cells in the B-cell population, as well as an increase in memory B cells associated with tumor control [86], have been observed in NSCLC and RCC cohorts treated with PD-L1 antibodies [87]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.